ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC.

Eun Ji Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.